Senior insider sale
Chief Financial Officer at PUMA BIOTECHNOLOGY, INC. — senior position signals high conviction
$26.5K
4.54K shares
What this filing means
NOUGUES MAXIMO F plans to sell 4.54K shares of PUMA BIOTECHNOLOGY, INC. valued at approximately $26.5K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 1/6/2026ACC: 0001959173-26-000171
Officer· Chief Financial Officer
Since Nov 2018
4.54K
Shares to sell
$26.5K
Approx. market value
4.54K
Acquired (3 months)
1
Planned
Securities Acquired — Last 3 Months1
Restricted Stock Vesting
Compensation
1/2/2026
4.54KTotal acquired4.54K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
1/2/2026 | Restricted Stock Vesting Compensation | 4.54K | — |
| Total | 4.54K | ||
Planned & Completed Dispositions1
NASDAQPlanned
Units to sell
4.54K
Market value
$26.5K
1/6/2026
Total
Units
4.54K
Value
$26.5K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
1/6/2026 | 4.54K | $26.5K | NASDAQ | Planned |
| Total | 4.54K | $26.5K | ||